Genomic Aberrations Associated With Outcome in Anaplastic Oligodendroglial Tumors Treated Within the EORTC Phase III Trial 26951
Journal of Neuro-Oncology - Netherlands
doi 10.1007/s11060-010-0380-9
Full Text
Open PDFAbstract
Available in full text
Date
September 6, 2010
Authors
Publisher
Springer Science and Business Media LLC